Visibility Score
13/100
AI Mentions
3
AI Search Volume
154
As of June 25, 2026, Sakura Finetek (sakura-finetek.com) has an AI visibility score of 13 out of 100, based on 3 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 154 AI search volume. Compared to peers in the life sciences sector, Sakura Finetek ranks #7 of 7 in AI mention share of voice.
Sakura Finetek is a Japan-based medical diagnostics company in the IVD/Diagnostics segment, registered with the U.S. FDA. This report tracks how Sakura Finetek appears in AI search — ChatGPT, Google AI Overview and other answer engines.
Sakura Finetek has 3 total AI mentions across 2 tracked platforms, generating 154 in AI search volume. ChatGPT accounts for the largest share at 67% of mentions.
No brand entity data available.
When AI assistants answer questions involving Sakura Finetek, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
Sakura Finetek ranks #7 out of 7 competitors in AI mention share of voice, capturing 0% of total mentions. Thermo Fisher Scientific leads with 55.2K AI mentions. Competitors tracked include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Agilent Technologies.
| Company | Mentions | AI Vol |
|---|---|---|
| sakura-finetek.com (You) | 3 | 154 |
| thermofisher.com (Thermo Fisher Scientific) | 55.2K | 29.5M |
| roche.com (Roche Diagnostics) | 5.9K | 2.0M |
| qiagen.com (QIAGEN) | 5.8K | 2.9M |
| agilent.com (Agilent Technologies) | 5.0K | 2.0M |
| bio-rad.com (Bio-Rad Laboratories) | 4.2K | 1.6M |
| grifols.com (Grifols) | 3.5K | 6.5M |
This is a static snapshot. VayoMed helps life sciences brands monitor AI mentions, track competitors, and build the content and citation signals that make AI platforms more likely to recommend them.